FDA Under Pressure To Alter Accelerated Approval Program
The necessity to update and alter the FDA's now-contentious rapid approval strategy is highlighted by...
Less Prostate Cancer Testing Leads To More Advanced Tumours
According to data from the U.S. Department of Veterans Affairs (VA), a reduction in prostate...
Scientists At ICR Research Cancer Response To New Treatments
Researchers discovered that by turning off the function of two genes, stomach tumours can become...
CDC Suggests Pairing Novavax COVID Shot With Pfizer, Moderna
The Centers for Disease Control and Prevention on October 19 advised adults in the United States...
FDA To Fund $38 Million To Fuel 4-Year Rare Disease Research
A total of $38 million has been granted by the US Food and Drug Administration...
US-Supplied Ebola Antibodies And Antivirals Reach Uganda
Remdesivir from Gilead Sciences and MBP134, an experimental Ebola antibody drug from Mapp Biopharmaceutical Inc.,...
US Healthcare Saves $21 Billion From Biosimilar Rivalry
Amgen's market forecast for 2022 explains how competition has led to healthcare cost savings and...
FDA Searching For Ways To Support Customised Gene Therapy
Peter Marks, a top official at the Food and Drug Administration, is not tasked with...
Merck-Moderna Sign Cancer Vaccine Deal Worth $250 Million
On October 12, 2022, Moderna revealed that Merck, also known as MSD outside of the...
Inflation Spurs Pharmaceuticals To Focus On Sustainability
Late in September, the trade group Medicines for Europe wrote an open letter to the...
